Crestwood Advisors Group LLC Eli Lilly & CO Transaction History

Crestwood Advisors Group LLC

$4.5 Billion
Q1 2024

A detailed history of Crestwood Advisors Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Crestwood Advisors Group LLC holds 36,690 shares of LLY stock, worth $33.6 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

36,690

Previous 33,927 8.14%

Holding current value

$33.6 Million

Previous $19.8 Million 44.33%

% of portfolio

0.63%

Previous 0.47%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $1.64 Million - $2.19 Million	2,763 Added 8.14%	36,690 $28.5 Million
Q4 2023 Jan 29, 2024	BUY	$525.19 - $619.13 $945,342 - $1.11 Million	1,800 Added 5.6%	33,927 $19.8 Million
Q3 2023 Nov 15, 2023	BUY	$434.7 - $599.3 $1.23 Million - $1.69 Million	2,827 Added 9.65%	32,127 $17.3 Million
Q2 2023 Aug 15, 2023	BUY	$350.74 - $468.98 $5,261 - $7,034	15 Added 0.05%	29,300 $13.7 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $8,387 - $9,850	-27 Reduced 0.09%	29,285 $10.1 Million

Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $6,109 - $7,118	19 Added 0.06%	29,312 $10.7 Million
Q3 2022 Oct 26, 2022	BUY	$296.48 - $337.87 $16,899 - $19,258	57 Added 0.19%	29,293 $9.47 Million
Q2 2022 Jul 07, 2022	SELL	$278.73 - $327.27 $36,792 - $43,199	-132 Reduced 0.45%	29,236 $9.48 Million
Q1 2022 Apr 12, 2022	SELL	$234.69 - $291.66 $321,994 - $400,157	-1,372 Reduced 4.46%	29,368 $8.41 Million
Q4 2021 Feb 15, 2022	SELL	$224.85 - $279.04 $137,158 - $170,214	-610 Reduced 1.95%	30,740 $8.49 Million
Q3 2021 Nov 03, 2021	SELL	$221.6 - $272.71 $3,324 - $4,090	-15 Reduced 0.05%	31,350 $7.24 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $997,538 - $1.29 Million	-5,525 Reduced 14.98%	31,365 $7.2 Million
Q1 2021 Apr 21, 2021	SELL	$164.32 - $212.72 $61,784 - $79,982	-376 Reduced 1.01%	36,890 $6.89 Million
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $4.46 Million - $5.9 Million	34,159 Added 1099.42%	37,266 $6.29 Million
Q3 2020 Oct 06, 2020	SELL	$146.22 - $169.13 $2,047 - $2,367	-14 Reduced 0.45%	3,107 $460,000
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $12,141 - $14,612	89 Added 2.94%	3,121 $512,000
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $11,309 - $13,998	-95 Reduced 3.04%	3,032 $421,000
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $35,390 - $43,834	331 Added 11.84%	3,127 $411,000
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $75,927 - $82,589	-711 Reduced 20.27%	2,796 $313,000
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $47,861 - $55,866	432 Added 14.05%	3,507 $389,000
Q1 2019 May 09, 2019	SELL	$111.31 - $131.02 $5,899 - $6,944	-53 Reduced 1.69%	3,075 $399,000
Q3 2018 Nov 15, 2018	BUY	$85.86 - $107.31 $8,586 - $10,731	100 Added 3.3%	3,128 $336,000
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $26,116 - $29,973	-345 Reduced 10.23%	3,028 $0
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $250,310 - $295,474	3,373 New	3,373 $261,000

Others Institutions Holding LLY

# of Institutions

3,725

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crestwood Advisors Group LLC with notifications on news.

Account

Crestwood Advisors Group LLC Eli Lilly & CO Transaction History